Clinical and Patient Reported Outcomes from Patients with Non-alcoholic Fatty Liver Disease Across the World: Data from the Global NASH/NAFLD Registry.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, cilt.20, ss.2296-2312, 2022 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 20
- Basım Tarihi: 2022
- Doi Numarası: 10.1016/j.cgh.2021.11.004
- Dergi Adı: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
- Sayfa Sayıları: ss.2296-2312
- Anahtar Kelimeler: Disease Burden, Work Productivity, Outcomes, Chronic Diseases, Metabolic Syndrome, UNITED-STATES, PREVALENCE
- Recep Tayyip Erdoğan Üniversitesi Adresli: Evet
Özet
BACKGROUND & AIMS: Globally, nonalcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease. We assessed the clinical presentation and patient-reported outcomes (PROs) among NAFLD patients from different countries.